BSH/EHA YoungEHA Research Meeting 2024 Session 2
Tracks
Track 3
| Saturday, April 27, 2024 |
| 11:35 AM - 12:35 PM |
| Room 4 |
Speaker
Dr Rebecca Ling
Clinician Dphil
University of Oxford
LIN28B is necessary for initiation and maintenance of infant KMT2A-AFF1 acute lymphoblastic leukaemia
11:35 AM - 11:50 AM
Dr Hector Huerga Encabo
Postdoctoral Fellow
The Francis Crick Institute
Impact of TET2 mutations on hematopoietic stem cell resilience to immune-related stress
11:50 AM - 12:05 PM
Miss Hamdah Alsaeedi
PHD
University of Liverpool
Targeting the PH domain in BTK-mediated gene expression within Mantle cell lymphoma cells
12:05 PM - 12:20 PM
Dr Oscar Atkins
Doctoral Clinical Fellow
The Francis Crick Institute
CREBBP/EP300 Inhibition Synergises with CHOP Chemotherapy in CREBBP-Mutated DLBCL
12:20 PM - 12:35 PMChair
Aditi Dey
Post Doctoral Scientist
University College London
Simon Richardson
Clinician Scientist
University of Cambridge
